These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25693050)

  • 1. An augmented SMS intervention to improve access to antenatal CD4 testing and ART initiation in HIV-infected pregnant women: a cluster randomized trial.
    Dryden-Peterson S; Bennett K; Hughes MD; Veres A; John O; Pradhananga R; Boyer M; Brown C; Sakyi B; van Widenfelt E; Keapoletswe K; Mine M; Moyo S; Asmelash A; Siedner M; Mmalane M; Shapiro RL; Lockman S
    PLoS One; 2015; 10(2):e0117181. PubMed ID: 25693050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.
    Weigel R; Hosseinipour MC; Feldacker C; Gareta D; Tweya H; Chiwoko J; Gumulira J; Kalulu M; Mofolo I; Kamanga E; Mwale G; Kadzakumanja A; Jere E; Phiri S
    Trop Med Int Health; 2012 Jun; 17(6):751-9. PubMed ID: 22487553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Text messaging for maternal and infant retention in prevention of mother-to-child HIV transmission services: A pragmatic stepped-wedge cluster-randomized trial in Kenya.
    Odeny TA; Hughes JP; Bukusi EA; Akama E; Geng EH; Holmes KK; McClelland RS
    PLoS Med; 2019 Oct; 16(10):e1002924. PubMed ID: 31577792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda: a prospective observational cohort study.
    Siedner MJ; Santorino D; Lankowski AJ; Kanyesigye M; Bwana MB; Haberer JE; Bangsberg DR
    BMC Med; 2015 Jul; 13():160. PubMed ID: 26149722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
    Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial.
    Aliyu MH; Blevins M; Audet CM; Kalish M; Gebi UI; Onwujekwe O; Lindegren ML; Shepherd BE; Wester CW; Vermund SH
    Lancet HIV; 2016 May; 3(5):e202-11. PubMed ID: 27126487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.
    Langwenya N; Phillips TK; Brittain K; Zerbe A; Abrams EJ; Myer L
    J Int AIDS Soc; 2018 Jun; 21(6):e25133. PubMed ID: 29939483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy in antenatal care to increase treatment initiation in HIV-infected pregnant women: a stepped-wedge evaluation.
    Killam WP; Tambatamba BC; Chintu N; Rouse D; Stringer E; Bweupe M; Yu Y; Stringer JS
    AIDS; 2010 Jan; 24(1):85-91. PubMed ID: 19809271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy.
    Mnyani CN; McIntyre JA; Myer L
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):260-4. PubMed ID: 22487589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2016; 28 Suppl 1(sup1):114-8. PubMed ID: 26922939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Point-of-Care CD4 Testing on Retention in Care Among HIV-Positive Pregnant and Breastfeeding Women in the Context of Option B+ in Zimbabwe: A Cluster Randomized Controlled Trial.
    Joseph J; Gotora T; Erlwanger AS; Mushavi A; Zizhou S; Masuka N; Boeke CE; Mangwiro AZ
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S190-S197. PubMed ID: 28498189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot programme for the rapid initiation of antiretroviral therapy in pregnancy in Cape Town, South Africa.
    Myer L; Zulliger R; Black S; Pienaar D; Bekker LG
    AIDS Care; 2012; 24(8):986-92. PubMed ID: 22519561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMS messaging to improve ART adherence: perspectives of pregnant HIV-infected women in Kenya on HIV-related message content.
    Ronen K; Unger JA; Drake AL; Perrier T; Akinyi P; Osborn L; Matemo D; O'Malley G; Kinuthia J; John-Stewart G
    AIDS Care; 2018 Apr; 30(4):500-505. PubMed ID: 29254362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Mother-Infant Pair Clinics and Short-Text Messaging Service (SMS) Reminders on Retention of HIV-Infected Women and HIV-Exposed Infants in eMTCT Care in Malawi: A Cluster Randomized Trial.
    Mwapasa V; Joseph J; Tchereni T; Jousset A; Gunda A
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S123-S131. PubMed ID: 28498181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early ART initiation among HIV-positive pregnant women in central Mozambique: a stepped wedge randomized controlled trial of an optimized Option B+ approach.
    Cowan JF; Micek M; Cowan JF; Napúa M; Hoek R; Gimbel S; Gloyd S; Sherr K; Pfeiffer JT; Chapman RR
    Implement Sci; 2015 Apr; 10():61. PubMed ID: 25924668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.
    Myer L; Kamkuemah M; Kaplan R; Bekker LG
    Trop Med Int Health; 2013 Nov; 18(11):1400-5. PubMed ID: 24102663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.